Why the study?
Does intracoronary streptokinase administration improve left ventricular function and reduce mortality in patients with evolving acute myocardial infarction?
Does intracoronary streptokinase administration improve left ventricular function and reduce mortality in patients with evolving acute myocardial infarction?
Intracoronary streptokinase administered up to 18 hours after symptom onset in acute myocardial infarction improves left ventricular function and reduces mortality in patients without severe heart failure or shock.
No takes yet. Share an insight, caveat, or question.
Supports potential benefit of late intracoronary streptokinase in non-shock AMI; leaves open randomized confirmation before practice change.
Smalling et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: